Patents by Inventor Romain Boidot

Romain Boidot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for predicting the risk of developing radio-induced cancer
    Publication number: 20210332438
    Abstract: The present invention relates to methods for predicting the risk of developing a sarcoma after radiotherapy treatment.
    Type: Application
    Filed: June 21, 2018
    Publication date: October 28, 2021
    Inventors: Philippe MAINGON, Céline MIRJOLET, Romain BOIDOT, Caroline TRUNTZER
  • SIGNATURE OF CYCLING HYPOXIA AND USE THEREOF FOR THE PROGNOSIS OF CANCER
    Publication number: 20160186270
    Abstract: The present invention relates to a signature comprising at least 2 cycling hypoxia markers. The present invention also relates to a non-invasive method for the prognosis of cancer in a subject, wherein said method comprises assessing the expression of markers of a signature of the invention in a sample from said subject; and to a kit for implementing this non-invasive method.
    Type: Application
    Filed: August 1, 2014
    Publication date: June 30, 2016
    Inventors: Olivier FERON, Romain BOIDOT, Samuel BRANDERS, Pierre DUPONT, Thibault HELLEPUTTE
  • Method for Predicting Responsiveness to a Treatment With an Anti-HER2 Antibody
    Publication number: 20110189185
    Abstract: The invention provides an in vitro method for predicting whether a patient would be responsive to a treatment with an anti-HER2 blocking agent, such as trastuzumab, which method comprises determining the expression level of at least 4 genes in a biological sample of said patient, wherein said genes are GPR22, PEX19, GRHL2 and DERL1. The invention further provides a DNA chip for performing such method.
    Type: Application
    Filed: June 8, 2009
    Publication date: August 4, 2011
    Applicant: Centre Georges Francois Leclerc
    Inventors: Sarab Lizard, Romain Boidot, Laurent Arnould, Bruno Coudert, Pierre Fumoleau